Chad J. Kolean - Feb 24, 2022 Form 3/A - Amendment Insider Report for Cellectar Biosciences, Inc. (CLRB)

Role
Chief Financial Officer
Signature
/s/ Christina Blakley, Attorney-in-fact for Chad Kolean
Stock symbol
CLRB
Transactions as of
Feb 24, 2022
Transactions value $
$0
Form type
3/A - Amendment
Date filed
4/15/2022, 05:00 PM
Date Of Original Report
Feb 24, 2022
Previous filing
Feb 24, 2022
Next filing
Jan 18, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding CLRB Common Stock 240 Feb 24, 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This amendment to Form 3 is being filed to report the Reporting Person's direct ownership of 240 shares of Common Stock, which were inadvertently omitted from his Form 3 filed February 24, 2022.